Skip to search.
 TSX Down 0.08% TSX Ventures Up 0.73%

Geron Corporation (GERN)

-NasdaqGS
2.86 Down 0.09(3.05%) Feb 5, 4:00PM EST
Prev Close:2.95
Open:2.95
Bid:2.81 x 300
Ask:3.44 x 100
1y Target Est:7.50
Beta:2.5957
Next Earnings Date:N/A
Day's Range:2.85 - 2.95
52wk Range:2.60 - 5.30
Volume:2,107,075
Avg Vol (3m):3,072,740
Market Cap:452.51M
P/E (ttm):N/A
EPS (ttm):-0.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNDown 3.05%452.51M
BMYDown 0.12%99.48B
GSKDown 0.54%98.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.00
Quarterly EPS Est (Dec-15) :-0.05
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback